Two recent disappointing clinical trials of highly-anticipated weight-loss drugs have made it clear that it is too early to ...

A new study shows that GLP-1 drugs offer health benefits such as reducing risks for heart disease but also carry potential risks like gastrointestinal issues.

When it comes to medically assisted weight loss, there’s two main schools of thought: either weight loss drugs, like the ...

Researchers in China may have uncovered a surprising ally in the fight against sugar cravings and metabolic disorders: a ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have other untapped potentials to reduce health risks.

Palantir Technologies (NASDAQ:PLTR) has been described as the best pure-play stock in artificial intelligence. The market ...

President Trump rescinded a Biden-era Executive Order that would have lowered the copays for some drugs to $2 for Medicare ...

Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took researchers by surprise.

A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like drugs also appear to ...

While Ozempic has been praised for its ability to induce weight loss and treat a range of health conditions, it could also ...